secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cue Biopharma, Inc. (CUE)
CIK:        0001645460
Form:       8-K
Filed at:   2026-06-03T20:16:49+00:00
Accession:  0001193125-26-255479
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cue Biopharma stockholders approve 2026 stock plan and warrant issuance
-----------------------------------------------------------------------

- Warrant share issuance from May 2026 licensing transaction approved (1.78M For, 113K Against).
- 2026 Stock Incentive Plan approved with 1.26M For, 632K Against, 2,687 Abstain.
- Adjournment proposal approved (1.30M For, 582K Against); not needed as main proposals passed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1645460/000119312526255479/0001193125-26-255479-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1645460/000119312526255479/cue-20260601.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-255479

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer